Why Heart Failure in CHD Differs From Acquired Heart Failure
Heart failure in adults with congenital heart disease (CHD-HF) is fundamentally different from the heart failure managed by general cardiologists. In CHD, ventricular failure often occurs in the context of structurally abnormal anatomy — a systemic right ventricle, a single ventricle Fontan circulation, or a biventricular repair with residual hemodynamic lesions — rather than in a structurally normal dilated or ischemic heart. Standard heart failure therapies developed in large randomized controlled trials of patients with dilated or ischemic cardiomyopathy may not apply directly to CHD-related ventricular dysfunction. Evidence for many therapies in specific CHD anatomies is extrapolated from case series, registry data, and clinical judgment — which is precisely why heart failure in CHD belongs in the hands of ACHD subspecialists who understand both the anatomic substrate and the evolving evidence base.
Heart Failure in the Fontan Circulation
The Fontan operation — used to palliate single-ventricle congenital heart defects such as hypoplastic left heart syndrome, tricuspid atresia, and double inlet left ventricle — connects the venous circulation directly to the pulmonary arteries, bypassing the right ventricle entirely. While the Fontan circulation allows survival into adulthood, it is inherently non-pulsatile, dependent on low pulmonary vascular resistance, and carries a lifelong risk of Fontan failure. Fontan failure encompasses a spectrum of complications including protein-losing enteropathy (PLE), plastic bronchitis, hepatic fibrosis and cirrhosis (Fontan-associated liver disease), and ventricular failure. Early identification and active management — including diuretics, afterload reduction, pacemaker optimization, catheter-based interventions, and in selected patients, heart transplantation — can meaningfully extend and improve quality of life.
Have questions about your care?
Speak directly with our team — no referral needed for most consultations.
Systemic Right Ventricle Failure
In patients with congenitally corrected transposition of the great arteries (ccTGA) or D-transposition repaired with the atrial switch procedure (Mustard or Senning), the right ventricle — a chamber designed for low-pressure pulmonary circulation — functions as the systemic ventricle for life. This anatomic mismatch leads to progressive systemic RV dysfunction, tricuspid regurgitation, and eventually heart failure in a significant proportion of patients by the fourth or fifth decade. Management includes optimized guideline-directed medical therapy (GDMT), device therapy (cardiac resynchronization therapy and ICD implantation), and referral for advanced therapies including transplantation when clinically indicated.
ACHD Heart Failure Care in New York
Congenital Heart Compass Medical PLLC provides specialized heart failure evaluation and management for adults with congenital heart disease across New York State. We coordinate with heart failure specialists, electrophysiologists, hepatologists, and transplant programs at major centers to ensure the full spectrum of ACHD-related heart failure is managed collaboratively. Patients in Rochester, Buffalo, Syracuse, Albany, and across Upstate and Western New York can access expert telemedicine evaluation without traveling to a distant academic center.
Reviewed by Dr. Pradeepkumar Charla, MD, MBA, FAAP, FACC
Pediatric & Adult Congenital Cardiologist — Congenital Heart Compass Medical PLLC
Last reviewed:
Medical disclaimer: This content is for educational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment. Always consult a qualified cardiologist for decisions about your congenital heart disease care.